Retrospective Study
Copyright ©The Author(s) 2022.
World J Gastroenterol. Apr 21, 2022; 28(15): 1574-1587
Published online Apr 21, 2022. doi: 10.3748/wjg.v28.i15.1574
Figure 1
Figure 1 Patient flowchart.
Figure 2
Figure 2 Kaplan-Meier curves of ICC recurrence: Time after surgery. ICC: Intrahepatic cholangiocarcinoma; MS: Median survival.
Figure 3
Figure 3 Kaplan-Meier curves of ICC recurrence: Time after recurrence. ICC: Intrahepatic cholangiocarcinoma; MS: Median survival.
Figure 4
Figure 4 Venn diagram of recurrent location pattern. Intrahepatic lesions (25/54, 46.3%) were the most common recurrence sites, followed by concurrent liver and lymph nodes (13/54, 24.1%).
Figure 5
Figure 5 Kaplan-Meier curves of ICC recurrence: multimodality therapy versus no multimodality therapy. Patients with recurrent ICC who received multimodality therapy had a significantly better long-term survival after recurrence than those who did not (P = 0.026, log-rank test). ICC: Intrahepatic cholangiocarcinoma; MS: Median survival.